ETALPHA

This brand name is authorized in Austria, Estonia, Spain, Finland, Netherlands

Active ingredients

The drug ETALPHA contains one active pharmaceutical ingredient (API):

1 Alfacalcidol UNII URQ2517572 - ALFACALCIDOL

Alfacalcidol is Vitamin D-hormone analog (an active metabolite of Vitamin D), which performs important functions in regulation of the calcium balance and the bone metabolism and is activated by the enzyme 25-hydroxylase (converted rapidly in the liver to 1,25-dihydroxyvitamin D) for systemic and in osteoblasts for local D-hormone actions. Read about Alfacalcidol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A11CC03	Alfacalcidol	A Alimentary tract and metabolism → A11 Vitamins → A11C Vitamin A and D, incl. combinations of the two → A11CC Vitamin D and analogues
Discover more medicines within A11CC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1724071
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 55906, 61022, 61023
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 419242, 546507, 553826, 553842
Country: NL	Z-Index G-Standaard	Identifier(s): 12382094, 13622161
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 14737, 18864, 33685, 3549, 54763